Showing results (41-50 of 73) with videos related to
Sort By:
Pageof 8
Investigative Ophthalmology & Visual Science|July 18, 2017
Iris Freckles a Potential Biomarker for Chronic Sun DamageChristoph Schwab, Christoph Mayer, Iris Zalaudek, et al.Acta Dermato-Venereologica|May 14, 2014
Autonomic nervous tone in vitiligo patients--a case-control studyEva-Maria Trapp, Michael Trapp, Francesca Sampogna, et al.Acta Dermato-Venereologica|January 15, 2015
Psychological Stress and Immunological Modulations in Early-stage Melanoma PatientsErika Richtig, Eva Maria Trapp, Alexander Avian, et al.Acta Dermato-Venereologica|March 8, 2014
Higher psychological and psychovegetative strain in adolescents with atypical pigment naeviMichael Trapp, Josef Wilhelm Egger, Hans-Peter Kapfhammer, et al.Journal of Personalized Medicine|December 29, 2022
Suction Drain Volume following Axillary Lymph Node Dissection for Melanoma-When to Remove Drains? A Retrospective Cohort StudyRaimund Winter, Alexandru Tuca, Paul Wurzer, et al.Dermatology (Basel, Switzerland)|March 23, 2007
Clinical epidemiology of invasive cutaneous malignant melanoma in the Austrian province Styria in the years 2001-2003 and its relationship with local geographical, meteorological and economic dataErika Richtig, Andrea Berghold, Gerold Schwantzer, et al.European Journal of Cancer (Oxford, England : 1990)|October 9, 2017
Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanomaTeresa M Petrella, Caroline Robert, Erika Richtig, et al.Advances in Therapy|December 28, 2020
A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB-IVM1a Melanoma in Four European CountriesAlexander C J van Akkooi, Sebastian Haferkamp, Sophie Papa, et al.Cancers|July 14, 2023
Assessing the Performance of a Novel Stool-Based Microbiome Test That Predicts Response to First Line Immune Checkpoint Inhibitors in Multiple Cancer TypesIrina Robinson, Maximilian Johannes Hochmair, Manuela Schmidinger, et al.Journal for Immunotherapy of Cancer|February 20, 2021
Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and GermanyJulia Maria Ressler, Matthias Karasek, Lukas Koch, et al.Pageof 8